La Jolla Pharmaceutical (LJPC)
NASDAQ: LJPC
· Real-Time Price · USD
6.19
-0.02 (-0.32%)
At close: Aug 15, 2022, 10:00 PM
La Jolla Pharmaceutical Revenue Breakdown
| Period Ending | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|
| License And Other Revenue Revenue | 32K | 16K | 155K | 1.53M | 11.06M | 8.64M |
| License And Other Revenue Revenue Growth | +100.00% | -89.68% | -89.89% | -86.14% | +28.04% | n/a |
| Product Revenue | 10.51M | 10.41M | 12.05M | 11.78M | n/a | n/a |
| Product Revenue Growth | +0.98% | -13.65% | +2.33% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.76M | 10.27M | 9M | 8.63M | 9M | 8.76M | 9.11M | 12.49M | 8.68M | 8.15M | 10.71M | 10.78M | 11.32M | 12.32M | 18.84M | 21.14M | 22.16M | 23.02M | 11.94M | 7.39M | 6.02M | 5.5M | 4.83M | 4.35M | 3.47M | 4.05M | 2.81M | 3.35M | 3.97M | 3.8M |
| Selling, General, and Administrative Revenue Growth | -4.98% | +14.12% | +4.30% | -4.05% | +2.75% | -3.85% | -27.11% | +43.98% | +6.44% | -23.88% | -0.68% | -4.78% | -8.09% | -34.62% | -10.86% | -4.62% | -3.70% | +92.81% | +61.53% | +22.72% | +9.43% | +13.89% | +11.11% | +25.48% | -14.48% | +44.13% | -16.13% | -15.58% | +4.64% | n/a |
| Research and Development Revenue | 154K | 27K | 1.06M | 1.28M | 1.11M | 1.56M | 1.43M | 3.62M | 8.78M | 9.18M | 20.86M | 21.18M | 22.04M | 21.24M | 27.57M | 30.44M | 30.87M | 28.43M | 26.91M | 19.09M | 20.81M | 17.77M | 20.18M | 16.99M | 12.4M | 12.69M | 9.46M | 7.78M | 6.69M | 5.17M |
| Research and Development Revenue Growth | +470.37% | -97.45% | -17.74% | +15.35% | -28.50% | +9.03% | -60.49% | -58.81% | -4.38% | -55.98% | -1.52% | -3.91% | +3.76% | -22.94% | -9.44% | -1.39% | +8.58% | +5.65% | +40.94% | -8.24% | +17.13% | -11.95% | +18.74% | +36.99% | -2.28% | +34.26% | +21.51% | +16.38% | +29.32% | n/a |